Millennium Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Buy |
52,229
+50,081
| +2,332% | +$443K | ﹤0.01% | 3400 |
|
|
2025
Q1 | $23.1K | Sell |
2,148
-45,727
| -96% | -$492K | ﹤0.01% | 3876 |
|
|
2024
Q4 | $613K | Buy |
47,875
+12,372
| +35% | +$158K | ﹤0.01% | 3157 |
|
|
2024
Q3 | $980K | Sell |
35,503
-4,975
| -12% | -$137K | ﹤0.01% | 2935 |
|
|
2024
Q2 | $1.17M | Sell |
40,478
-61,356
| -60% | -$1.78M | ﹤0.01% | 2790 |
|
|
2024
Q1 | $4.54M | Buy |
101,834
+56,883
| +127% | +$2.54M | ﹤0.01% | 2043 |
|
|
2023
Q4 | $1.74M | Buy |
44,951
+35,175
| +360% | +$1.36M | ﹤0.01% | 2529 |
|
|
2023
Q3 | $287K | Sell |
9,776
-658
| -6% | -$19.3K | ﹤0.01% | 3484 |
|
|
2023
Q2 | $664K | Sell |
10,434
-6,864
| -40% | -$437K | ﹤0.01% | 3129 |
|
|
2023
Q1 | $816K | Buy |
+17,298
| New | +$816K | ﹤0.01% | 3182 |
|
|
2022
Q2 | – | Sell |
-14,093
| Closed | -$1.42M | – | 5355 |
|
|
2022
Q1 | $1.42M | Sell |
14,093
-5,326
| -27% | -$538K | ﹤0.01% | 3306 |
|
|
2021
Q4 | $3.01M | Buy |
19,419
+16,143
| +493% | +$2.5M | ﹤0.01% | 2637 |
|
|
2021
Q3 | $970K | Sell |
3,276
-3,282
| -50% | -$972K | ﹤0.01% | 3682 |
|
|
2021
Q2 | $2.13M | Buy |
+6,558
| New | +$2.13M | ﹤0.01% | 3094 |
|